Repligen Corp

RGEN NASDAQ Santé & Biotech États-Unis US7599161095
132.72 $
1.03 %

Repligen Corp développe et commercialise des produits biotechnologiques, principalement pour la fabrication de médicaments biologiques.

Price history of Repligen Corp
Price history of Repligen Corp

Performance & Momentum

6 Months 17.90 %
1 Year 0.55 %
3 Years 19.59 %
5 Years 30.70 %

Similar stocks to Repligen Corp

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone